Is a complete SRZN research report available?

No complete published report is available for Surrozen, Inc. (SRZN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Surrozen, Inc. (SRZN)

NASDAQ: SRZN · USD

$30.5

+0.98 (+3.3%)· Recorded snapshot

Market cap	533.8M
Revenue (ttm)	11.5M
Net income (ttm)	-324.6M
EPS (ttm)	-$32.2
Shares out	17.5M
Volume	124,232
Beta	0.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11.5M
Net income (ttm): -324.6M
EPS (ttm): -$32.2
Market cap: 533.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001824893
Company name	Surrozen, Inc.
Country	United States
Country code	US
CUSIP number	86889P208
Earnings date	2026-11-10
Earnings time	amc
Employees	44
Employees change	3
Employees growth	7.32%
Enterprise value	$438.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US86889P2083
Last 10-K release date	2026-03-23
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2023-12-14
Last stock split type	Reverse
Market cap	$533.8M
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	No
Price	$30.51
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	SRZN
U.S. state	California
Website	https://www.surrozen.com

Metric

Value

Amount currency

USD

CIK code

0001824893

Company name

Surrozen, Inc.

Country

United States

Country code

CUSIP number

86889P208

Earnings date

2026-11-10

Earnings time

amc

Employees

Employees change

Employees growth

7.32%

Enterprise value

$438.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US86889P2083

Last 10-K release date

2026-03-23

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2023-12-14

Last stock split type

Reverse

Market cap

$533.8M

Market cap category

Small-Cap

Next earnings date

2026-11-10

Options

Price

$30.51

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

SRZN

U.S. state

California

Website

https://www.surrozen.com

Metric	Value
Earnings yield	-105.5%
EV/Sales	37.48x
FCF / EV yield	-8.11%
FCF yield	-6.64%
Forward EV/Sales	162.18x
Forward P/S	198.17x
P/S ratio	45.79x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-105.5%

EV/Sales

37.48x

FCF / EV yield

-8.11%

FCF yield

-6.64%

Forward EV/Sales

162.18x

Forward P/S

198.17x

P/S ratio

45.79x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	-200.38%
Operating margin	-385.28%
Pretax margin	-2,885.33%
Profit per employee	$-7.4M
Profitable quarters	1
Revenue per employee	$261,614
ROA	-25.39%
ROA (5Y)	-33.56%
ROCE	-41.61%
SBC / revenue	60.85%

Metric

Value

Gross margin

-200.38%

Operating margin

-385.28%

Pretax margin

-2,885.33%

Profit per employee

$-7.4M

Profitable quarters

Revenue per employee

$261,614

ROA

-25.39%

ROA (5Y)

-33.56%

ROCE

-41.61%

SBC / revenue

60.85%

Metric	Value
EPS growth years	0
Net income growth (Q)	26.24%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-8.8%
Revenue growth (Q)	408.65%
Revenue growth (QoQ)	0%
Revenue growth 3Y	-2.71%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth (Q)

26.24%

Net income growth quarters

Net income growth years

Revenue growth

-8.8%

Revenue growth (Q)

408.65%

Revenue growth (QoQ)

Revenue growth 3Y

-2.71%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-222,000
Depreciation and amortization	$222,000
EBIT	$-44.4M
EBITDA	$-44.1M
EPS	$-32.19
FCF per share	$-2.00
Financing cash flow	$46.6M
Free cash flow	$-35M
Free cash flow minus SBC	$-42M
Gross profit	$-23.1M
Investing cash flow	$-222,000
Net cash flow	$11.6M
Net income	$-324.6M
Operating cash flow minus SBC	$-41.8M
Operating income	$-44.4M
Revenue	$11.5M
Stock-based compensation	$7M

Metric

Value

Capital expenditures

$-222,000

Depreciation and amortization

$222,000

EBIT

$-44.4M

EBITDA

$-44.1M

EPS

$-32.19

FCF per share

$-2.00

Financing cash flow

$46.6M

Free cash flow

$-35M

Free cash flow minus SBC

$-42M

Gross profit

$-23.1M

Investing cash flow

$-222,000

Net cash flow

$11.6M

Net income

$-324.6M

Operating cash flow minus SBC

$-41.8M

Operating income

$-44.4M

Revenue

$11.5M

Stock-based compensation

$7M

Metric	Value
Altman Z-Score	-7.1
Book value per share	$-18.60
Long-term assets	$6.2M
Long-term liabilities	$325.3M
Net cash (debt)	$95.7M
Net cash / market cap	18.16%
Net cash growth	15.5%
Piotroski F-Score	1
Property, plant and equipment	$5.6M
Shareholders' equity	$-218.7M
Tangible book value	$-218.7M
Tangible book value per share	$-18.60
Total assets	$115.6M
Total cash	$102M
Total debt	$6.3M
Total liabilities	$334.3M
WACC	6.73%

Metric

Value

Altman Z-Score

-7.1

Book value per share

$-18.60

Long-term assets

$6.2M

Long-term liabilities

$325.3M

Net cash (debt)

$95.7M

Net cash / market cap

18.16%

Net cash growth

15.5%

Piotroski F-Score

Property, plant and equipment

$5.6M

Shareholders' equity

$-218.7M

Tangible book value

$-218.7M

Tangible book value per share

$-18.60

Total assets

$115.6M

Total cash

$102M

Total debt

$6.3M

Total liabilities

$334.3M

WACC

6.73%

Metric	Value
Asset turnover	0.11
Current assets	$109.4M
Current liabilities	$9M
Current ratio	12.14
Net working capital	$338,000
Quick ratio	11.88
Working capital	$100.4M
Working capital turnover	0.12

Metric

Value

Asset turnover

0.11

Current assets

$109.4M

Current liabilities

$9M

Current ratio

12.14

Net working capital

$338,000

Quick ratio

11.88

Working capital

$100.4M

Working capital turnover

0.12

Metric	Value
Buyback yield / dilution	-115.86%
Dividend yield	0%
Shareholder yield	-115.86%

Metric

Value

Buyback yield / dilution

-115.86%

Dividend yield

Shareholder yield

-115.86%

Metric	Value
150-day SMA	$25.26
1D price change	3.32%
1M price change	1.93%
1M total return	1.93%
1W price change	19.77%
1W total return	19.77%
1Y price change	116.15%
1Y return CAGR	116.27%
1Y total return	116.15%
20-day SMA	$26.53
200-day SMA	$25.01
3M price change	51.99%
3M total return	51.99%
3Y price change	412.08%
3Y return CAGR	72.34%
3Y total return	412.08%
50-day SMA	$24.08
50-day SMA vs 200-day SMA	50under200
52-week high	$37.83
52-week high date	2026-09-25
52-week low	$11.39
52-week low date	2025-11-05
5Y price change	-68.83%
5Y return CAGR	-20.8%
5Y total return	-68.83%
6M price change	0.53%
6M total return	0.53%
All-time high	$210.00
All-time high date	2021-09-17
All-time low	$4.50
All-time low date	2023-11-09
Average true range (ATR)	$2.58
Average volume	553.9K
Beta (1Y)	2.27
Beta (2Y)	0.02
Beta (5Y)	0.47
Change from 52-week high	-19.35%
Change from 52-week low	167.87%
Change from all-time high	-85.66%
Change from all-time low	569.11%
Change from open	3.04%
Day's gap	0.27%
Dollar volume	$3.8M
High price	$30.51
Low price	$29.61
Monthly RSI	58.99
Open price	$29.61
Position in 52-week range	100%
Premarket change	-0.07%
Premarket close	$29.53
Premarket price	$29.51
Previous close	$29.53
Price vs 150-day SMA	19.2%
Price vs 20-day SMA	13.49%
Price vs 200-day SMA	20.4%
Price vs 50-day SMA	25.02%
Relative volume	0.22
RSI	61.82
Sharpe ratio	1.04
Sharpe ratio (3Y)	0.9
Sharpe ratio (5Y)	0.25
Sortino ratio	2.71
Sortino ratio (3Y)	1.73
Sortino ratio (5Y)	0.47
Volume	124.2K
Weekly RSI	57.56
YTD price change	33.23%
YTD total return	33.23%

Metric

Value

150-day SMA

$25.26

1D price change

3.32%

1M price change

1.93%

1M total return

1.93%

1W price change

19.77%

1W total return

19.77%

1Y price change

116.15%

1Y return CAGR

116.27%

1Y total return

116.15%

20-day SMA

$26.53

200-day SMA

$25.01

3M price change

51.99%

3M total return

51.99%

3Y price change

412.08%

3Y return CAGR

72.34%

3Y total return

412.08%

50-day SMA

$24.08

50-day SMA vs 200-day SMA

50under200

52-week high

$37.83

52-week high date

2026-09-25

52-week low

$11.39

52-week low date

2025-11-05

5Y price change

-68.83%

5Y return CAGR

-20.8%

5Y total return

-68.83%

6M price change

0.53%

6M total return

0.53%

All-time high

$210.00

All-time high date

2021-09-17

All-time low

$4.50

All-time low date

2023-11-09

Average true range (ATR)

$2.58

Average volume

553.9K

Beta (1Y)

2.27

Beta (2Y)

0.02

Beta (5Y)

0.47

Change from 52-week high

-19.35%

Change from 52-week low

167.87%

Change from all-time high

-85.66%

Change from all-time low

569.11%

Change from open

3.04%

Day's gap

0.27%

Dollar volume

$3.8M

High price

$30.51

Low price

$29.61

Monthly RSI

58.99

Open price

$29.61

Position in 52-week range

100%

Premarket change

-0.07%

Premarket close

$29.53

Premarket price

$29.51

Previous close

$29.53

Price vs 150-day SMA

19.2%

Price vs 20-day SMA

13.49%

Price vs 200-day SMA

20.4%

Price vs 50-day SMA

25.02%

Relative volume

0.22

RSI

61.82

Sharpe ratio

1.04

Sharpe ratio (3Y)

0.9

Sharpe ratio (5Y)

0.25

Sortino ratio

2.71

Sortino ratio (3Y)

1.73

Sortino ratio (5Y)

0.47

Volume

124.2K

Weekly RSI

57.56

YTD price change

33.23%

YTD total return

33.23%

Metric	Value
Float	9.9M
Float percentage	56.66%
Shares change (QoQ)	111.32%
Shares change (YoY)	115.86%
Shares held by insiders	0.39%
Shares held by institutions	45.29%
Shares outstanding	17.5M
Short % of float	31.59%
Short % of shares	17.9%
Short ratio	2.5 days

Metric

Value

Float

9.9M

Float percentage

56.66%

Shares change (QoQ)

111.32%

Shares change (YoY)

115.86%

Shares held by insiders

0.39%

Shares held by institutions

45.29%

Shares outstanding

17.5M

Short % of float

31.59%

Short % of shares

17.9%

Short ratio

2.5 days

Surrozen, Inc. (SRZN)

Price

Financial snapshot

Fair-value bridge

Latest news · SRZN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SRZN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SRZN

Frequently asked questions